Latest News

Johnson & Johnson’s HIV vaccine fails mid-stage Africa study

0

Johnson & Johnson said on Tuesday its experimental vaccine failed to provide sufficient protection against HIV in sub-Saharan Africa to young women.

Apple pledges another $30 million to racial equity initiatives

Previous article

‘They have better things to do’ – Major Republican donors are staying away from Trump

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News